Researchers have made a breakthrough in treating triple-negative breast cancer with a new immunotherapy approach using CAR-NKT cells. This cell therapy has shown promise in effectively killing tumors, with some reports suggesting it could be a universal or "off-the-shelf" treatment. However, the specific applications and effectiveness of this therapy, including its potential use for other types of cancer, such as pancreatic cancer, are still being explored and reported.